We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+9.24%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$27.7B
AUM Growth
+$2.29B
(+9%)
Cap. Flow
+$341M
Cap. Flow
% of AUM
1.23%
Top 10 Holdings %
Top 10 Hldgs %
18.59%
Holding
1,249
New
118
Increased
427
Reduced
427
Closed
119
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$113M |
| 2 |
Apple
AAPL
|
+$69M |
| 3 |
Pfizer
PFE
|
+$57M |
| 4 |
Verizon
VZ
|
+$50.4M |
| 5 |
Microsoft
MSFT
|
+$48.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$100M |
| 2 |
Linde
LIN
|
+$85.1M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$55.4M |
| 4 |
Ferrari
RACE
|
+$51.7M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$44.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.12% |
| 2 | Healthcare | 20.97% |
| 3 | Financials | 10.86% |
| 4 | Consumer Discretionary | 10.19% |
| 5 | Industrials | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Honda
HMC
$41.8B
| $27.8K | ﹤0.01% |
1,216
-155
| -11% | -$3.59K |
|
1077
Mizuho Financial
MFG
$135B
| $25.1K | ﹤0.01% |
8,842
-1,402
| -14% | -$3.3K |
|
1078
Vale
VALE
$61.6B
| $22.7K | ﹤0.01% |
1,339
| – | – |
|
|
CAJ
1079
DELISTED
Canon, Inc.
CAJ
| $16.2K | ﹤0.01% |
747
-107
| -13% | -$2.38K |
|
1080
TAL Education Group
TAL
$6.52B
| $11.3K | ﹤0.01% |
+1,600
| New | +$8.87K |
|
|
YRD
1081
Yiren Digital
YRD
$88.4M
| $8.76K | ﹤0.01% |
6,397
| – | – |
|
1082
HSBC
HSBC
$350B
| $2.77K | ﹤0.01% |
89
| – | – |
|
1083
Aecom
ACM
$8.26B
| – | – |
-10,100
| Closed | -$691K |
|
1084
Aclaris Therapeutics
ACRS
$814M
| – | – |
-18,200
| Closed | -$286K |
|
|
AGEN
1085
Agenus
AGEN
$322M
| – | – |
-525
| Closed | -$21.1K |
|
1086
A.O. Smith
AOS
$7.78B
| – | – |
-127,835
| Closed | -$6.21M |
|
1087
Applovin
APP
$111B
| – | – |
-11,207
| Closed | -$218K |
|
1088
Aramark
ARMK
$15.4B
| – | – |
-16,301
| Closed | -$367K |
|
1089
Associated Banc-Corp
ASB
$5.73B
| – | – |
-23,300
| Closed | -$468K |
|
|
EFOR
1090
Everforth Inc
EFOR
$1.39B
| – | – |
-52,775
| Closed | -$4.77M |
|
1091
Autohome
ATHM
$2.46B
| – | – |
-99,500
| Closed | -$2.86M |
|
1092
Avista
AVA
$3.04B
| – | – |
-18,900
| Closed | -$700K |
|
1093
Brookfield Renewable
BEPC
$5.39B
| – | – |
-95,596
| Closed | -$3.12M |
|
1094
BJ's Restaurants
BJRI
$1.28B
| – | – |
-55,800
| Closed | -$1.33M |
|
1095
Builders FirstSource
BLDR
$6.48B
| – | – |
-4,500
| Closed | -$265K |
|
1096
Brown & Brown
BRO
$22.5B
| – | – |
-14,835
| Closed | -$897K |
|
1097
BWX Technologies
BWXT
$13.4B
| – | – |
-8,100
| Closed | -$408K |
|
|
CADE
1098
DELISTED
Cadence Bank
CADE
| – | – |
-35,100
| Closed | -$892K |
|
|
CGC
1099
Canopy Growth
CGC
$389M
| – | – |
-15,663
| Closed | -$428K |
|
1100
Colliers International
CIGI
$4.63B
| – | – |
-6,400
| Closed | -$587K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q4 2022 Portfolio in Review
As of Q4 2022, Axa held 1,249 positions worth $27.7B, up 9% from $25.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Axa's Q4 2022 filing shows 118 new, 427 increased, 427 reduced and 119 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 119,000 shares worth $41.8M. The largest sale was Oracle, an estimated $100M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
- Axa's largest Q4 2022 buy was Vanguard S&P 500 ETF: 119,000 shares worth $41.8M.
- Axa added most to Tesla in Q4 2022, an estimated $113M increase.
- Axa's biggest Q4 2022 reduction was Oracle, cutting an estimated $100M.
- Axa fully exited Abiomed Inc in Q4 2022, selling an estimated $55.4M.
- Axa's ten largest holdings make up 19% of its $27.7B portfolio in Q4 2022.
- Axa opened 118 new positions and closed 119 in Q4 2022.
- Axa's portfolio value rose 9% quarter-over-quarter to $27.7B.
Based on Axa's 13F filing for Q4 2022, filed 14 Feb 2023.